Gyrotonic exercise for elders with breast cancer and Behcet disease
Official title: Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
Run by Cairo University · NCT07929116 · Data updated 2026-11-12
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 75 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza, Dokki) |
| Status | Recruiting |
| Started | November 30, 2026 |
| Main results expected | May 30, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07929116 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are breast cancer survivors with Behcet disease who are medically stable and without cardiac, respiratory, or renal failure.
✕Probably not a fit
Patients with significant comorbidities or contraindications to exercise may not benefit and could be at risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this study, forty eligible participants with Behcet disease and breast cancer will be randomly assigned to either a gyrotonic exercise program—three sessions per week for 12 weeks—or to a wait-list control. The trial will measure safety and any changes in physical function and well-being to see if the exercise is feasible and beneficial for this specific group. The intervention is supervised exercise, with exclusions for those facing cardiac, respiratory, or renal failure. Conducted at Cairo University in Giza and Dokki, this study aims to provide preliminary data on the role of gyrotonic training in this comorbidity setting.
Why it matters
Potential benefit: If successful, participants may experience improvements in physical function and quality of life related to exercise.
How similar studies have gone: There is limited published experience with gyrotonic training in this exact combination of conditions, making this a novel exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * beast cancer survivors * behcet diseas patients Exclusion Criteria: * cardiac or repiratory or renal failure patients
Where it's running
-
Cairo University
Giza, Dokki, Egypt Recruiting
Study contacts
- Principal investigator: Ali MA Ismail, phd — Cairo University
- Study coordinator: Ali MA Ismail, PhD
- Email: ali.mohamed@pt.cu.edu.eg
- Phone: +201005154209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
-
Mindful Self-Compassion for Breast Cancer Survivors
This study tests whether a Mindful Self-Compassion program added to usual care helps breast cancer survivors aged 20 and older who finished treatment within the last year to feel less distressed and experience more psychological growth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.